Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

In combination with BIOTRONIK Home Monitoring the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden

News | Remote Monitoring

REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients

June 13, 2023 — A recent study highlights that implantable cardioverter-defibrillator (ICD) patients with new-onset ...

June 13, 2023

Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization therapy (CRT) among patients who were not able to be treated with conventional CRT and epicardial leads.

News | Cardiac Resynchronization Therapy Devices (CRT)

The WiSE CRT System Offers an Endocardial Alternative to Conventional CRT

May 22, 2023 — Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronization ...

May 22, 2023

Results from global trial of the POLARx Cryoablation System* meet safety and effectiveness endpoints

News | Left Atrial Appendage (LAA) Occluders

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System

May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...

May 22, 2023

Heart Rhythm 2023, the society's 44th annual meeting, taking place May 19-21, in New Orleans

Feature | HRS | By Melinda Taschetta-Millane

HRS23 Announces Late-breaking Clinical Trials and Science Sessions

The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...

May 17, 2023

Analysis finds most athletes had no cardiac events over seven years, underscoring importance of shared decision-making

News | Implantable Cardioverter Defibrillator (ICD)

Cardiac Risks Appear Low for Elite Athletes with Diagnosed, Treated Genetic Heart Disease

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

March 07, 2023

Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

February 17, 2023

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

August 29, 2022

According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is recalling Cobalt/Crome Implantable Cardioverter Defibrillators (ICDs) and Resynchronization Therapy Defibrillators (CRT-Ds) after receiving reports that some devices have triggered short circuit protection (SCP) alerts during the second phase of high voltage waveform therapy and delivered reduced-energy electric shocks.

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Recalls Cobalt XT, Cobalt and Crome ICDs and CRT-Ds for Risk that Devices May Issue a Short Circuit Alert and Deliver Reduced Energy Shock During High Voltage Therapy

August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is ...

August 19, 2022

A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of sudden cardiac death worldwide

News | Implantable Cardioverter Defibrillator (ICD)

First-in-Human Trial Shows Promise for Hard-to-Treat Ventricular Tachycardia Heart Rhythms

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

August 18, 2022

Impact of the United States Supreme Court Reversal of Roe vs. Wade for patients with heart rhythm conditions

News | HRS

HRS Statement on Reversal of Roe v. Wade and HRS2023 in New Orleans

August 4, 2022 — The Heart Rhythm Society (HRS) is a professional society representing a diverse population of ...

August 04, 2022

The global automated external defibrillators market size was valued at USD 717 million in 2021

News | Implantable Cardioverter Defibrillator (ICD)

Automated External Defibrillators Market is Projected to Reach $1.62 Billion by 2030

July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is ...

July 22, 2022

Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD),

News | Sudden Cardiac Arrest

Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...

July 13, 2022

The ICDs market is segmented into three categories; single chamber ICDs, dual chamber ICDs, and subcutaneous ICDs, which are used to monitor heart rhythms and deliver therapy to correct heart rates that are too fast, a condition that can lead to sudden cardiac arrest.

News | Implantable Cardioverter Defibrillator (ICD)

Lower Pricing Alone Unlikely to Win Sales in the Implantable Cardioverter Defibrillators Market

June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common ...

June 10, 2022

Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding this year's conference. More than 7,700+ heart rhythm professionals from around the world whose participation during Heart Rhythm 2022

News | HRS

Heart Rhythm 2022 Highlights

May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...

May 17, 2022

Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration Play Mute Remaining Time -3:23 Picture-in-Picture Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee

Feature | Cardiovascular Business

Top 10 Cardiology Videos on DAIC for April

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

May 09, 2022